![]() | STOCKCHASEWhat the experts are saying! |
| There are 1 registered members and 53 guests viewing the site. | Rss Top Picks Feed | Rss Daily Feed |
|
| TOP PICK | 38.970 | Elizabeth Dater | Given with what's going on with Vioxx and Cellebrex, this company is very important as the FDA will be asking for lengthier testing on these areas. Looks on this as a fabulous growth story. | 2004-12-17 | |
| TOP PICK | 37.480 | Elizabeth Dater | 2004-07-09 | ||
| TOP PICK | 35.680 | Ed Brown | To a lot of testing and research for larger biotech companies. In a sweet spot. | 2004-05-07 |